Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept
Abstract Background Not all patients with major depressive disorder (MDD) benefit from the US Food and Drug Administration‐approved use of repetitive transcranial magnetic stimulation (rTMS) at the dorsolateral prefrontal cortex. We may be undertreating depression with this one‐size‐fits‐all rTMS st...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2023-11-01
|
| Серія: | Brain and Behavior |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/brb3.3268 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|